User profiles for Gowtham Rao

Gowtham Adamane Rao

Janssen Research & Development
Verified email at its.jnj.com
Cited by 1532

Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study

X Li, A Ostropolets, R Makadia, A Shoaibi, G Rao… - bmj, 2021 - bmj.com
Objective To quantify the background incidence rates of 15 prespecified adverse events of
special interest (AESIs) associated with covid-19 vaccines. Design Multinational network …

Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self …

…, A Ostropolets, RW Park, A Prats-Uribe, GA Rao… - MedRxiv, 2020 - medrxiv.org
Background Hydroxychloroquine has recently received Emergency Use Authorization by the
FDA and is currently prescribed in combination with azithromycin for COVID-19 pneumonia. …

Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death

GA Rao, JR Mann, A Shoaibi, CL Bennett… - The Annals of Family …, 2014 - Annals Family Med
PURPOSE Azithromycin use has been associated with increased risk of death among
patients at high baseline risk, but not for younger and middle-aged adults. The Food and Drug …

[HTML][HTML] Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study

…, RW Park, A Prats-Uribe, GA Rao… - The Lancet …, 2020 - thelancet.com
Background Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid
arthritis, has received much negative publicity for adverse events associated with its …

Cardiac risks associated with antibiotics: azithromycin and levofloxacin

ZK Lu, J Yuan, M Li, SS Sutton, GA Rao… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Azithromycin and levofloxacin have been shown to be efficacious in treating
infections. The adverse drug events associated with azithromycin and levofloxacin were …

[HTML][HTML] Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study

X Li, A Ostropolets, R Makadia, A Shaoibi, G Rao… - Medrxiv, 2021 - ncbi.nlm.nih.gov
Background As large-scale immunization programs against COVID-19 proceed around the
world, safety signals will emerge that need rapid evaluation. We report population-based, age…

[HTML][HTML] Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study

…, J Park, JD Posada, A Prats-Uribe, G Rao… - Nature …, 2020 - nature.com
Comorbid conditions appear to be common among individuals hospitalised with coronavirus
disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the …

Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C

GA Rao, PK Pandya - Gastroenterology, 2011 - Elsevier
BACKGROUND & AIMS: Patients with chronic hepatitis C infection are 2- to 3-fold more likely
to develop type 2 diabetes, which reduces their chances of achieving a sustained virologic …

[HTML][HTML] Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network

…, RW Park, A Prats-Uribe, N Pratt, G Rao… - BMC Medical Research …, 2022 - Springer
Background We investigated whether we could use influenza data to develop prediction
models for COVID-19 to increase the speed at which prediction models can reliably be …

[HTML][HTML] Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a …

…, R Makadia, K Haynes, AG Sena, G Rao… - …, 2023 - thelancet.com
Background Adverse events of special interest (AESIs) were pre-specified to be monitored
for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with …